Alchemab Launches First-in-Human Trial of ATLX-1282, Secures 32 Million USD Financing Boost
Alchemab Therapeutics, a biopharmaceutical company that develops naturally occurring therapeutic antibodies from resilient individuals, has announced the initiation of its first-in-human phase 1 study of ATLX-1282.
Pharma Investment | 10/09/2025 | By Darshana
With this year’s theme, ‘Epicentre of Progress’, the event showcases solutions for the entire value chain, from research to end-of-line packaging.
Pharma Investment | 29/08/2023 | By Manvi | 464
With this year’s theme, ‘Epicentre of Progress’, the event showcases solutions for the entire value chain, from research to end-of-line packaging.
Pharma Investment | 29/08/2023 | By Manvi | 464
Tube Investments of India forays into pharma sector
The company will engage in contract manufacturing, research and development of API
Pharma Investment | 15/03/2023 | By Sudeep Soparkar | 1015
Merck to invest $132 million in MilliporeSigma in France
The investment will create more than 800 jobs by the end of 2028
Pharma Investment | 15/09/2022 | By Sudeep Soparkar | 831
Catalent to invest $2.2 M in clinical supply facility
The investment will provide an additional 31,000 square feet, representing a 20 per cent increase in floor space
Pharma Investment | 08/09/2022 | By Sudeep Soparkar | 565
Rs.6000 crore investment promised in Global Ayush Summit 2022
28 companies commit to invest Rs. 6,000 crore till second day of first Global Ayush Investment and Innovation Summit 2022
Pharma Investment | 22/04/2022 | By Sudeep Soparkar | 296
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy